Mechanisms of Neuronal Degeneration in Alzheimer's Disease

Slides:



Advertisements
Similar presentations
Etiopathogenesis of Alzheimer's disease
Advertisements

ALZHEIMER PATHOLOGY AND NEUROPLASTICITY AD ATTACKS NEUROPLASTIC MECHANISMS NEUROPLASTICITY AS THE FOCUS OF THE ALZHEMIER ATTACK ALZHEIMER ATTACK AS A MODEL.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
Molecular Motors in Neurons: Transport Mechanisms and Roles in Brain Function, Development, and Disease Nobutaka Hirokawa, Shinsuke Niwa, Yosuke Tanaka.
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Mechanisms of Age-Related Macular Degeneration Jayakrishna Ambati, Benjamin J. Fowler Neuron Volume 75, Issue 1, Pages (July 2012) DOI: /j.neuron
Syed H. Omar, Christopher J. Scott, Adam S. Hamlin, Hassan K. Obied 
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Alzheimer’s Disease 1 in 9 people in the US aged 65 and older
The Neuropathology and Neurobiology of Traumatic Brain Injury
The Neuropathology and Neurobiology of Traumatic Brain Injury
Immunotherapeutic Approaches for Alzheimer’s Disease
Disorders with Complex Genetics
Nat. Rev. Neurol. doi: /nrneurol
Acetylation Unleashes Protein Demons of Dementia
Michele Curcio, Frank Bradke  Neuron 
Oxidative stress in Alzheimer's disease
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Protein Misfolding, Amyloid Formation, and Neurodegeneration
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
Beyond Making Ends Meet: DNA-PK, Metabolism, and Aging
The aging oocyte—can mitochondrial function be improved?
Type 3 Deiodinase in Hypoxia: To Cool or to Kill?
Shining light on vitamin D trials in chronic kidney disease
Structural Neurology: Are Seeds at the Root of Neuronal Degeneration?
Yee-Ming Chan, Yuh Nung Jan  Neuron 
Anti-Tau Antibodies: Hitting the Target
Nat. Rev. Neurol. doi: /nrneurol
Progress in Molecular Genetics of Heritable Skin Diseases: The Paradigms of Epidermolysis Bullosa and Pseudoxanthoma Elasticum  Jouni Uitto, Leena Pulkkinen,
Todd E. Golde, Lon S. Schneider, Edward H. Koo  Neuron 
Dendritic Cells Cell Volume 106, Issue 3, Pages (August 2001)
G Protein Signaling and Asymmetric Cell Division
Eph Nomenclature Committee  Cell 
Michele Curcio, Frank Bradke  Neuron 
Volume 11, Issue 1, Pages (July 2018)
Jekyll & Hyde: Evolution of a Superfamily
The Role of Apolipoprotein E in Alzheimer's Disease
Transmissible human proteopathies: an expanding field
Genotype/Phenotype Analysis of a Photoreceptor-Specific ATP-Binding Cassette Transporter Gene, ABCR, in Stargardt Disease  Richard Alan Lewis, Noah F.
A Sequel to the Tale of p25/Cdk5 in Neurodegeneration
The Evolution of Genetics: Alzheimer’s and Parkinson’s Diseases
Tau Phosphorylation, Tangles, and Neurodegeneration
Sorting Out Presenilins in Alzheimer’s Disease
Gap Junctions: Basic Structure and Function
Mechanisms Underlying Inflammation in Neurodegeneration
Elucidating the Role of TREM2 in Alzheimer’s Disease
Neuroplasticity Failure in Alzheimer's Disease
Dissecting Risk Haplotypes in Sporadic Alzheimer's Disease
Volume 88, Issue 5, Pages (December 2015)
Type 3 Deiodinase in Hypoxia: To Cool or to Kill?
New Frontiers in Alzheimer's Disease Genetics
Rik van der Kant, Lawrence S.B. Goldstein  Developmental Cell 
Tauomics and Kinetics in Human Neurons and Biological Fluids
The Ubiquitin Proteasome System in Neurodegenerative Diseases
DYRK protein kinases Current Biology
Yee-Ming Chan, Yuh Nung Jan  Neuron 
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Genomic imprinting Current Biology
Volume 142, Issue 4, Pages (April 2012)
Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders
Volume 7, Issue 1, Pages 1-11 (July 1997)
Volume 24, Issue 1, Pages 7-8 (July 2016)
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
Neurodegenerative Tauopathies
Cellular Alchemy and the Golden Age of Reprogramming
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

Mechanisms of Neuronal Degeneration in Alzheimer's Disease Bruce A. Yankner  Neuron  Volume 16, Issue 5, Pages 921-932 (May 1996) DOI: 10.1016/S0896-6273(00)80115-4

Figure 1 Inherited Mutations That Cause AD (A) APP. Sites of inherited mutations surrounding or within the Aβ domain are shown with asterisks. The mutations either increase Aβ production, alter the length of Aβ, or increase Aβ aggregation. (B) The seven transmembrane domain protein S182. Shown are the sites of five inherited mutations in S182 and a mutation in the homologous protein STM2. Five of the six mutations are proximal to a transmembrane domain. Neuron 1996 16, 921-932DOI: (10.1016/S0896-6273(00)80115-4)

Figure 2 Aβ Fibril Formation and Potential Mechanisms of Neurotoxicity Age-related factors or inherited mutations induce the formation of Aβ fibrils, which may cause neuronal degeneration through several potential cellular mechanisms. Neuron 1996 16, 921-932DOI: (10.1016/S0896-6273(00)80115-4)

Figure 3 Potential Pathogenic Mechanisms Involving ApoE Individuals carrying the E4 allele of ApoE are at increased risk of developing AD. The E3 and E4 alleles may differentially affect Aβ fibril formation, tau phosphorylation, or cholesterol transport involved in neurite outgrowth and synaptogenesis. Neuron 1996 16, 921-932DOI: (10.1016/S0896-6273(00)80115-4)